Seattle, Washington — According to state and local economic development sources Neoleukin Therapeutics plans to invest $1,029,722.00 to build out 22,267 square feet of new space in Seattle. The company plans to occupy the new space at 188 E Blaine St in Seattle, on or about December 1, 2020. According to the company website At Neoleukin Therapeutics, we are dedicated to developing medicines that transform lives. We believe that there is an urgent need for a paradigm shift in therapeutic protein discovery that overcomes a reliance on the building blocks that nature has provided. Our innovative computational platform allows us to design entirely new de novo proteins from the ground up to treat serious diseases, including cancer, inflammatory, and autoimmune disorders. We are a team of physicians, scientists, and innovators with a visionary focus to improve on nature and enable a truly customized approach to medicine. We are leading the protein design revolution. We invite you to join us on this journey.

To learn more about Neoleukin Therapeutics, visit http://www.neoleukin.com/

Company Contact:
Jonathan Drachman, Chief Executive Officer
https://www.linkedin.com/in/jonathan-drachman-66084016/
206-519-5300

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved